期刊
NEUROSCIENCE RESEARCH
卷 76, 期 1-2, 页码 1-9出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neures.2013.03.013
关键词
Angiogenesis; Spinal cord injury; VEGF; Wound healing; Mammals; FGF
资金
- BBSRC Doctoral Training Grant [DLAA.GBT1491]
- Wellcome Trust [092539/Z/10/Z]
- Wellcome Trust [092539/Z/10/Z] Funding Source: Wellcome Trust
Patients with spinal cord injury (SCI) are permanently paralysed and anaesthetic below the lesion. This morbidity is attributed to the deposition of a dense scar at the injury site, the cellular components of which secrete axon growth inhibitory ligands that prevent severed axons reconnecting with denervated targets. Another complication of SCI is wound cavitation where a fluid filled cyst forms in the peri-lesion neuropil, enlarging over the first few months after injury and causes secondary axonal damage. Wound healing after SCI is accompanied by angiogenesis, which is regulated by angiogenic proteins, produced in response to oxygen deprivation. Necrosis in and about the SCI lesion sites may be suppressed by promoting angiogenesis and the resulting neuropil protection will enhance recovery after SCI. This review addresses the use of angiogenic/wound-healing related proteins including vascular endothelial growth factor, fibroblast growth factor, angiopoietin-1, angiopoietin-2 and transforming growth factor-beta to moderate necrosis and axon sparing after SCI, providing a conducive environment for growth essential to functional recovery. (c) 2013 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据